Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...

For decades, cancer screening has relied on imaging, bloodwork, and invasive testing. Now, one biotech company is taking a different approach. They’re combining dogs, breath samples, and AI to help ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Non-small cell lung cancer is ...

Lung cancer remains the leading cause of cancer-related mortality worldwide despite advances in early detection and treatment. Furthermore, its epidemiology has undergone a profound transformation, ...

A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought. Originally designed to ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...

New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients? By Simar Bajaj More than half of patients with metastatic lung cancer don’t receive ...

Please provide your email address to receive an email when new articles are posted on . Less than half of older adults with metastatic lung cancer received systemic treatment. Findings underscore the ...

A new artificial intelligence tool called Sybil is helping doctors predict lung cancer risk years before it appears on scans, potentially closing gaps in current screening guidelines. Standard lung ...